Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zerbib

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
The American Journal of Physiology|December 9, 1998
Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humansF Zerbib, S Bruley Des Varannes, C Scarpignato, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1994
Alosetron does not affect the visceral perception of gastric distension in healthy subjectsF Zerbib, S Bruley des Varannes, R C Oriola, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 14, 2000
Modulation by colonic fermentation of LES function in humansT Piche, F Zerbib, S B Varannes, et al.
European Journal of Gastroenterology & Hepatology|August 10, 2000
Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patientsF Zerbib, C Lenk, B Sawan, et al.
The American Journal of Gastroenterology|January 6, 2006
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled studyT Schaeverbeke, N Broutet, F Zerbib, et al.
Gut|April 22, 2005
Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo)S Bruley des Varannes, F Mion, P Ducrotté, et al.
Alimentary Pharmacology & Therapeutics|June 16, 2011
Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective studyD Laharie, S Mesli, F El Hajbi, et al.
Journal of Crohn'S & Colitis|October 6, 2017
Frequency of and Factors Associated With Sexual Dysfunction in Patients With Inflammatory Bowel DiseaseP Rivière, C Zallot, P Desobry, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2011
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux diseaseF Zerbib, S Bruley des Varannes, S Roman, et al.
Acta Gastro-Enterologica Belgica|January 29, 1999
Is it justified to give antisecretory drugs before an endoscopy in case of symptoms suggestive of gastro-oesophageal reflux disease? Société Royale Belge de Gastro-entérolgieJ P Galmiche, B Delbende, F Zerbib, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
The American Journal of Physiology|December 9, 1998
Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humansF Zerbib, S Bruley Des Varannes, C Scarpignato, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1994
Alosetron does not affect the visceral perception of gastric distension in healthy subjectsF Zerbib, S Bruley des Varannes, R C Oriola, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 14, 2000
Modulation by colonic fermentation of LES function in humansT Piche, F Zerbib, S B Varannes, et al.
European Journal of Gastroenterology & Hepatology|August 10, 2000
Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patientsF Zerbib, C Lenk, B Sawan, et al.
The American Journal of Gastroenterology|January 6, 2006
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled studyT Schaeverbeke, N Broutet, F Zerbib, et al.
Gut|April 22, 2005
Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo)S Bruley des Varannes, F Mion, P Ducrotté, et al.
Alimentary Pharmacology & Therapeutics|June 16, 2011
Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective studyD Laharie, S Mesli, F El Hajbi, et al.
Journal of Crohn'S & Colitis|October 6, 2017
Frequency of and Factors Associated With Sexual Dysfunction in Patients With Inflammatory Bowel DiseaseP Rivière, C Zallot, P Desobry, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2011
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux diseaseF Zerbib, S Bruley des Varannes, S Roman, et al.
Acta Gastro-Enterologica Belgica|January 29, 1999
Is it justified to give antisecretory drugs before an endoscopy in case of symptoms suggestive of gastro-oesophageal reflux disease? Société Royale Belge de Gastro-entérolgieJ P Galmiche, B Delbende, F Zerbib, et al.
Pageof 8